Fumaric acid-d2
Fumaric acid-d2 is the deuterium labeled Fumaric acid[1]. Fumaric acid, associated with fumarase deficiency, is identified as an oncometabolite or an endogenous, cancer causing metabolite[2].
Product Specifications
CAS Number
24461-32-3
UNSPSC
12352211
Hazard Statement
H319
Target
Endogenous Metabolite
Type
Isotope-Labeled Compounds
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Purity
99.00
Solubility
DMSO : ≥ 100 mg/mL
Smiles
OC(/C([2H])=C([2H])/C(O)=O)=O
Molecular Formula
C4H2D2O4
Molecular Weight
118.08
Precautions
H319
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Whelan DT, et al. Fumaric aciduria: a new organic aciduria, associated with mental retardation and speech impairment. Clin Chim Acta. 1983 Aug 31;132 (3) :301-8.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-T774445-500MG 500 mg
2,4,5-Trichlorophenoxyacetic Acid Isobutyl Ester
Sign In for Pricing
View Details 
BNC680915-100 1x 100 µL
MiTF (Microphthalmia Transcription Factor) (MITF/915), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742180-100 1x 100 µL
EGFR (Epidermal Growth Factor Receptor) (F4), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details